What is NANOSYN?
NANOSYN operates as a premier Contract Development and Manufacturing Organization (CDMO), providing a comprehensive suite of services spanning chemistry, biology, API development, and advanced formulation. Headquartered in the San Francisco Bay Area, the company utilizes over 100,000 square feet of specialized laboratory and production space. Its core value proposition lies in its deep bench of Ph.D. scientists who deliver rapid, high-precision solutions to a broad spectrum of clients, ranging from emerging biotech startups to established top-tier pharmaceutical corporations and academic research institutions.
How much funding has NANOSYN raised?
NANOSYN has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in NANOSYN
PPP
Public-Private Partnership
What's next for NANOSYN?
With this major enterprise-level funding, NANOSYN is poised to scale its infrastructure and enhance its technological capabilities. The strategic allocation of these resources will likely focus on optimizing turnaround times for complex drug discovery projects and expanding its API manufacturing throughput. As the pharmaceutical industry continues to prioritize outsourcing for specialized R&D, NANOSYN is well-positioned to capture additional market share, solidifying its reputation as a critical partner in the global drug development pipeline.
See full NANOSYN company page
